SCHEMBL6707736

SCHEMBL6707736

N#Cc1ccc(NC(=O)c2noc3ccc(S(=O)(=O)N4CCOCC4)cc23)c(-c2nnn[nH]2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALB P02768 1/20 0.47
CSF1R P07333 1/20 0.42
ALDH1A1 P00352 7/20 0.41
KDM4E B2RXH2 3/20 0.41
RXFP1 Q9HBX9 2/20 0.41
USP2 O75604 2/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 1/20 0.39
GAA P10253 5/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
ATM Q13315 1/20 0.38
CREBBP Q92793 1/20 0.37
KMT2A Q03164 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
PABPC1 P11940 1/20 0.37
APOBEC3A P31941 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711700 0.89 ALB (0.46) ALBCSF1RALDH1A1KDM4ERXFP1
SCHEMBL6713434 0.89 MAPT (0.47) ALBALDH1A1KDM4ERXFP1USP2
SCHEMBL6711876 0.87 ALB (0.48) ALBCSF1RALDH1A1KDM4ERXFP1
SCHEMBL6710307 0.84 CSF1R (0.37) CSF1RALDH1A1KDM4EGAALMNA
SCHEMBL6707649 0.83 MEN1 (0.54) ALBALDH1A1KDM4EGAALMNA
SCHEMBL6833124 0.83 ALB (0.69) ALBALDH1A1KDM4ERXFP1USP2
SCHEMBL6708970 0.82 ALDH1A1 (0.44) ALDH1A1KDM4ERXFP1HPGDHSD17B10
SCHEMBL6709230 0.82 GPR27 (0.41) ALDH1A1KDM4ELMNAKMT2AMEN1
SCHEMBL6712224 0.81 HIF1A (0.34)
SCHEMBL6709290 0.81 GPR35 (0.34) ALDH1A1HPGDMAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 ALB 1298/4885CSF1R 1430/4885ALDH1A1 123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.